November 1, 2024 10:38 AM EDT
News Briefing

FDA re­moves hold on three CARs­gen CAR-T tri­als; Ono pass­es on itolizum­ab

ENDPOINTS

Plus, news about Kymera Ther­a­peu­tics, Nanoscope, Eu­prax­ia, Al­pha Cog­ni­tion and Eye­Point:

FDA lifts hold of CARs­gen’s CAR-T ther­a­pies: The FDA on Thurs­day

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bio­gen brings in med­ical chief as CFO plans re­tire­ment; Macro­Gen­ics CEO an­nounces de­par­ture

Es­sa’s shares tank as it looks for op­tions af­ter aban­don­ing prostate can­cer drug

No­vo Nordisk claims late-stage MASH vic­to­ry, con­tin­u­ing GLP-1's ex­pan­sion

UCB's an­ti-tau Alzheimer's pro­gram fails Phase 2 pri­ma­ry end­point, but high­lights pos­i­tive sec­on­daries

Q&A with Obe­si­ty So­ci­ety’s CEO as the field pre­pares for next-gen meds

Ex­clu­sive: Blood stem cell ther­a­py mak­er Garu­da gets new CEO, adds $47M

A service from the Financial Times